Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Tekton Research, Inc. /ID# 160008
mi
from
Austin, TX
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
DJL Clinical Research, PLLC /ID# 161414
mi
from
Charlotte, NC
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
STAT Research, Inc. /ID# 161416
mi
from
Dayton, OH
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Denver Arthritis Clinic, PC /ID# 159899
mi
from
Denver, CO
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Arthritis Treatment Center /ID# 160053
mi
from
Frederick, MD
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Baker City
mi
from
Baker City, OR
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Joe Lueken Cancer Center
mi
from
Bemidji, MN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Greenville Health System Cancer Institute-Laurens
mi
from
Clinton, SC
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Collierville
mi
from
Collierville, TN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UCHealth Memorial Hospital Central
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
The Women's Imaging Center
mi
from
Denver, CO
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Medical Center-EC Cancer Center
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Beaumont Hospital - Farmington Hills
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
OhioHealth Mansfield Hospital
mi
from
Mansfield, OH
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UH Seidman Cancer Center at Lake Health Mentor Campus
mi
from
Mentor, OH
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC-Coraopolis/Heritage Valley Radiation Oncology
mi
from
Moon, PA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Franciscan Health Mooresville
mi
from
Mooresville, IN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health - Park Rapids
mi
from
Park Rapids, MN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Newland Medical Associates-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University Hospitals Portage Medical Center
mi
from
Ravenna, OH
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Charles Health System-Redmond
mi
from
Redmond, OR
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Summit Cancer Care-Candler
mi
from
Savannah, GA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Baptist Memorial Hospital and Cancer Center-Desoto
mi
from
Southhaven, MS
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Bhadresh Nayak MD PC-Sterling Heights
mi
from
Sterling Heights, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ascension Saint Joseph Hospital
mi
from
Tawas City, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Thief River Falls Medical Center
mi
from
Thief River Falls, MN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Professional Building
mi
from
Warren, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
Status: Enrolling
Updated: 12/31/1969
AMITA Health Adventist
mi
from
LaGrange, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburg
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Psoriasis Clinical Trial
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis.
Status: Enrolling, Phase III
Updated: 12/31/1969
MetroBoston Clinical Partners
mi
from
Needham, MA
Click here to add this to my saved trials
Psoriasis Clinical Trial
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis.
Status: Enrolling, Phase III
Updated: 12/31/1969
MediSearch Clinical Trials
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Hamilton,
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Systemic Lupus Erythematosus Clinical Trial
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Esophageal Neoplasms Clinical Trial
First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Cancer Center ( Site 0018)
mi
from
Detroit, MI
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Gastro Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling, Phase
Updated: 12/31/1969
NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Treatment Naive Follicular Lymphoma Clinical Trial
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI HCA Midwest Health
mi
from
Kansas City, MO
Click here to add this to my saved trials
Treatment Naive Follicular Lymphoma Clinical Trial
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Cancer Affiliates
mi
from
Ocala, FL
Click here to add this to my saved trials
Treatment Naive Follicular Lymphoma Clinical Trial
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
St Joseph Mercy Hospital
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Hypertension Clinical Trial
Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure
Status: Enrolling
Updated: 12/31/1969
HealthPartners Institute
mi
from
Bloomington, MN
Click here to add this to my saved trials
Breast Cancer Female Clinical Trial
A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide
Status: Enrolling, Phase
Updated: 12/31/1969
Cross Cancer Institute
mi
from
Edmonton,
Click here to add this to my saved trials
Breast Cancer Female Clinical Trial
A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide
Status: Enrolling, Phase
Updated: 12/31/1969
Valley Breast Care and Women's Health Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Open-Label Study to Evaluate Efficacy and Safety of SCY-078 in Patients With Refractory or Intolerant Fungal Diseases
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical University of Graz Department of Internal Medicine, Department of Pulmology, Section for Infectious Disease and Tropical Medicine
mi
from
Graz,
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Open-Label Study to Evaluate Efficacy and Safety of SCY-078 in Patients With Refractory or Intolerant Fungal Diseases
Status: Enrolling, Phase III
Updated: 12/31/1969
Louisiana State University Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Epilepsy Clinical Trial
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
Status: Enrolling, Phase
Updated: 12/31/1969
Bronislava Shafran, MD PC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Psychiatry / Psychology, Reproductive Clinical Trial
A Clinical Trial of Intravenous Ganaxolone in Women With Postpartum Depression
Status: Enrolling, Phase II
Updated: 12/31/1969
Marinus Research Site
mi
from
Irving, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of 2 Treatment Regimens of Aztreonam for Inhalation Solution in Children With Cystic Fibrosis and New Onset Pseudomonas Aeruginosa Infection
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California San Francisco (UCSF) - Benioff Children's Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Malignant Solid Tumour Clinical Trial
Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Patients With Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Sanford Cancer Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Unhealthy Alcohol Use Clinical Trial
Financial Incentives, Randomization With Stepped Treatment Trial
Status: Enrolling
Updated: 12/31/1969
VA Medical Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Antibody-mediated Rejection Clinical Trial
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients
Status: Enrolling, Phase III
Updated: 12/31/1969
California Pacific
mi
from
San Francisco, CA
Click here to add this to my saved trials
Painful Diabetic Neuropathy Clinical Trial
Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain
Status: Enrolling
Updated: 12/31/1969
Georgia Pain Care
mi
from
Stockbridge, GA
Click here to add this to my saved trials
HER2-positive Breast Cancer Clinical Trial
Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
The University of Kansas Cancer Center, Westwood Campus
mi
from
Kansas City, KS
Click here to add this to my saved trials
Feeding Behavior Clinical Trial
Effect of Varying Proportions of Low and High Energy Dense Foods Over 5 Days in Preschool Children
Status: Enrolling
Updated: 12/31/1969
Laboratory for the Study of Human Ingestive Behavior
mi
from
University Park, PA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Registry of Outcomes From AntiReflux Surgery
Status: Enrolling, Phase
Updated: 12/31/1969
Gundersen Lutheran Medical Clinic Ltd
mi
from
La Crosse, WI
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Registry of Outcomes From AntiReflux Surgery
Status: Enrolling, Phase
Updated: 12/31/1969
Tampa Bay Reflux Center
mi
from
Riverview, FL
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saraland, AL
Click here to add this to my saved trials
Urinary Stones Clinical Trial
Prevention of Urinary Stones With Hydration
Status: Enrolling
Updated: 12/31/1969
Children's Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Baker City
mi
from
Baker City, OR
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner High Grove
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Indu and Raj Soin Medical Center
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Waldo County General Hospital
mi
from
Belfast, ME
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Joe Lueken Cancer Center
mi
from
Bemidji, MN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford
mi
from
Biddeford, ME
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Elizabeth Boardman Hospital
mi
from
Boardman, OH
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Laurens
mi
from
Clinton, SC
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
UCHealth Memorial Hospital Central
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Dayton Physician LLC-Miami Valley Hospital North
mi
from
Dayton, OH
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada-Horizon Ridge
mi
from
Henderson, NV
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-Kuakini
mi
from
Honolulu, HI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Center of The South Incorporated
mi
from
Houma, LA
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Regional Cancer Center at Indian Path Community Hospital
mi
from
Kingsport, TN
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
OptumCare Cancer Care at Oakey
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
OhioHealth Mansfield Hospital
mi
from
Mansfield, OH
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Marinette
mi
from
Marinette, WI
Click here to add this to my saved trials
Clinical Trial
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Nebraska Medicine-Village Pointe
mi
from
Omaha, NE
Click here to add this to my saved trials